BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30393013)

  • 1. MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis.
    Kumar R; Khandelwal N; Chander Y; Riyesh T; Tripathi BN; Kashyap SK; Barua S; Maherchandani S; Kumar N
    Antiviral Res; 2018 Dec; 160():126-136. PubMed ID: 30393013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants.
    Khandelwal N; Chander Y; Rawat KD; Riyesh T; Nishanth C; Sharma S; Jindal N; Tripathi BN; Barua S; Kumar N
    Antiviral Res; 2017 Aug; 144():196-204. PubMed ID: 28624461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hesperetin blocks poxvirus replication with a low tendency to select for drug-resistant viral variants.
    Verma A; Dedar RK; Kumar R; Chander Y; Kamboj H; Kumar G; Verma R; Kumari S; Sharma S; Tripathi BN; Barua S; Kumar N
    J Med Virol; 2024 Apr; 96(4):e29555. PubMed ID: 38546037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells.
    Huang XB; Yang CM; Han QM; Ye XJ; Lei W; Qian WB
    Acta Pharmacol Sin; 2018 Dec; 39(12):1894-1901. PubMed ID: 30297804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations.
    Khandelwal N; Chander Y; Kumar R; Riyesh T; Dedar RK; Kumar M; Gulati BR; Sharma S; Tripathi BN; Barua S; Kumar N
    Antiviral Res; 2020 Sep; 181():104870. PubMed ID: 32707051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α.
    Chander Y; Kumar R; Verma A; Khandelwal N; Nagori H; Singh N; Sharma S; Pal Y; Puvar A; Pandit R; Shukla N; Chavada P; Tripathi BN; Barua S; Kumar N
    Mol Biol Evol; 2022 Sep; 39(9):. PubMed ID: 35975687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
    Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
    Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence and phylogenetic analysis of host-range (E3L, K3L, and C7L) and structural protein (B5R) genes of buffalopox virus isolates from buffalo, cattle, and human in India.
    Bera BCh; Shanmugasundaram K; Barua S; Anand T; Riyesh T; Vaid RK; Virmani N; Bansal M; Shukla BN; Malik P; Singh RK
    Virus Genes; 2012 Dec; 45(3):488-98. PubMed ID: 22872567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
    Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses.
    Singh RK; Balamurugan V; Hosamani M; Kallesh DJ; Bhanuprakash V
    J Virol Methods; 2008 Dec; 154(1-2):146-53. PubMed ID: 18790707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROCK1/MLC2 inhibition induces decay of viral mRNA in BPXV infected cells.
    Kumar R; Chander Y; Khandelwal N; Verma A; Rawat KD; Shringi BN; Pal Y; Tripathi BN; Barua S; Kumar N
    Sci Rep; 2022 Oct; 12(1):17811. PubMed ID: 36280692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.
    Kane EM; Shuman S
    J Virol; 1995 Oct; 69(10):6352-8. PubMed ID: 7666536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line.
    Cherla RP; Lee SY; Mees PL; Tesh VL
    J Leukoc Biol; 2006 Feb; 79(2):397-407. PubMed ID: 16301326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein.
    Cuesta R; Xi Q; Schneider RJ
    J Virol; 2004 Jul; 78(14):7707-16. PubMed ID: 15220445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E.
    Kumar R; Afsar M; Khandelwal N; Chander Y; Riyesh T; Dedar RK; Gulati BR; Pal Y; Barua S; Tripathi BN; Hussain T; Kumar N
    Antiviral Res; 2021 May; 189():105056. PubMed ID: 33711336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxins activate translational regulation pathways in intestinal epithelial cells.
    Colpoys WE; Cochran BH; Carducci TM; Thorpe CM
    Cell Signal; 2005 Jul; 17(7):891-9. PubMed ID: 15763431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibits vaccinia virus replication in vitro.
    Damaso CR; Keller SJ
    Arch Virol; 1994; 134(3-4):303-19. PubMed ID: 8129618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.
    Lostalé-Seijo I; Martínez-Costas J; Benavente J
    J Virol; 2016 Sep; 90(18):8328-40. PubMed ID: 27440902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.
    Dreas A; Mikulski M; Milik M; Fabritius CH; Brzózka K; Rzymski T
    Curr Med Chem; 2017; 24(28):3025-3053. PubMed ID: 28164761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.